Log In
Print this Print this

glatiramer acetate (Glatopa) (M356)

  Manage Alerts
Collapse Summary General Information
Company Momenta Pharmaceuticals Inc.
DescriptionSelective major histocompatibility complex class II (MHCII) modulator
Molecular Target Major histocompatibility complex class II (MHCII)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentApproved
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing forms of multiple sclerosis (MS); Treat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation U.S. - Undisclosed Review (Treat relapsing-remitting multiple sclerosis (RRMS))
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today